Interleukin-6 (IL-6) and IL-17 Synergistically Promote Viral Persistence by Inhibiting Cellular Apoptosis and Cytotoxic T Cell Function

IL-17-mediated Bcl-2 expression regulates survival of fibroblast-like synoviocytes in rheumatoid arthritis through STAT3 activation

(2013) Seon-Yeong Lee et al.   ARTHRITIS RESEARCH & THERAPY

Interleukin-6 signaling pathway in targeted therapy for cancer

(2012) Yuqi Guo et al.   CANCER TREATMENT REVIEWS

IL-1 signal affects both protection and pathogenesis of virus-induced chronic CNS demyelinating disease

(2012) Byung S Kim et al.   Journal of Neuroinflammation

TLR3 signaling is either protective or pathogenic for the development of Theiler's virus-induced demyelinating disease depending on the time of viral infection

(2011) Young-Hee Jin et al.   Journal of Neuroinflammation

Melanoma Differentiation-Associated Gene 5 Is Critical for Protection against Theiler's Virus-Induced Demyelinating Disease

(2011) Y.-H. Jin et al.   JOURNAL OF VIROLOGY

C/EBP , C/EBP  Oncoproteins, or C/EBP  Preferentially Bind NF- B p50 Compared with p65, Focusing Therapeutic Targeting on the C/EBP:p50 Interaction

(2011) J. E. Dooher et al.   MOLECULAR CANCER RESEARCH

Theiler's virus infection induces TLR3-dependent upregulation of TLR2 critical for proinflammatory cytokine production

(2009) Eui Young So et al.   GLIA

Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection

(2009) Wanqiu Hou et al.   JOURNAL OF EXPERIMENTAL MEDICINE

IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway

(2009) Lin Wang et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Replication of Theiler's virus requires NF-κB-activation: Higher viral replication and spreading in astrocytes from susceptible mice

(2008) Min Hyung Kang et al.   GLIA